Dara-krd, Autologous Transplantation And Mrd Response-adapted Consolidation And Treatment Cessation

2023 11:44
Synopsis
Prof Luciano Costa talks to ecancer about his talk at ASH 2021: Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone ...

You Might Also Like

Dara-KRd, Autologous Transplantation and MRD Response-Adapted Consolidation and Treatment Cessation 5:41
Dara-krd, Autologous Transplantation And Mrd Response-adapte...
2022
MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD response-adapted co... 5:38
Master Trial Updates: Dara-krd Induction, Autologous Transpl...
2021
MRD-Based Dara-Krd Consolidation in Patients with Newly Diagnosed Multiple Myeloma: MASTER Trial 4:35
Mrd-based Dara-krd Consolidation In Patients With Newly Diag...
2020
MASTER trial: Dara-KRD, ASCT & MRD-directed therapy in myeloma 5:32
Master Trial: Dara-krd, Asct & Mrd-directed Therapy In Myelo...
2022
Can MRD guide treatment of post-transplant dara-KRd consolidation? 3:40
Can Mrd Guide Treatment Of Post-transplant Dara-krd Consolid...
2020
MASTER: Dara-KRd in patients with multiple myeloma 3:07
Master: Dara-krd In Patients With Multiple Myeloma
2022
Using MRD to analyze the benefit of autologous SCT in patients with myeloma 3:47
Using Mrd To Analyze The Benefit Of Autologous Sct In Patien...
2023
Daratumumab, Carfilzomib, Lenalidomide & Dexamethasone w/ MRD Res. Adapted Therapy in Newly Diag. MM 48:26
Daratumumab, Carfilzomib, Lenalidomide & Dexamethasone W/ Mr...
2023
Extended follow-up of the MASTER trial 2:17
Extended Follow-up Of The Master Trial
2024
Updates from the MASTER trial 2:56
Updates From The Master Trial
2023
Evaluating the addition of elotuzumab to KRd by MRD assessment: the future of MRD-guided treatment? 5:10
Evaluating The Addition Of Elotuzumab To Krd By Mrd Assessme...
2022
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.